search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
FRAGRANCE 57 Tyrosinase


100 80 60 40 20 0


0 IC50=0.088%


100 80 60 40 20 0


0.1 0.2 0.3 0.4 0.5 Elastase


100 80 60 40 20 0


0.00 0.10 IC50=0.144%


100 80 60 40 20 0


0.20 0.30 0.40 0.50 0.60 0.70 Fragrance concentration in assay medium (%) 0.80 0.90 1.00 0 0.6 0.7 Fragrance concentration in assay medium (%) 0.8 0.9 1 Collagenase


IC50=0.224%


0.000 0.1000 0.2000 0.3000 0.4000 0.5000 0.6000 0.7000 0.8000 0.9000 1.000 Fragrance concentration in assay medium (%)


ABTS


IC50=0.027%


0.1


0.2


0.3


0.4


0.5


0.6


0.7 Fragrance concentration in assay medium (%)


Figure 1: In vitro dose–response inhibition curves (ABTS, tyrosinase, collagenase, elastase) measured after integration into fragrance vehicles (internal dataset)


support and protection from daily environmental aggressors. Despite this relevance, formulation constraints


have historically limited the direct use of brown seaweed extracts in perfumed leave-on products. Typical issues include persistent marine or iodine-like odour notes and pronounced coloration, largely associated with naturally occurring algal pigments, particularly chlorophylls, which can impart green to dark brown hues. In conventional formulations, masking such


coloration often requires additional formulation strategies that can interfere with olfactory balance, diffusion, or overall fragrance character. For an active-fragrance system, these constraints are decisive: any active integration must be sensorially neutral within the fragrance concentrate and must not create physical instability (haze, precipitation, or phase separation) across diverse perfume profiles.


Bioactive fragrance technology: composition, solvation strategy, and stability requirements The incorporation of marine-derived cosmetic actives into fragrance concentrates poses specific formulation challenges that differ fundamentally from those encountered in conventional cosmetic matrices. Fragrance concentrates are complex multicomponent systems primarily designed to solubilize lipophilic materials, whereas algae-derived bioactive fractions are largely polar and poorly compatible with standard perfumery environments.


www.personalcaremagazine.com The bioactive fragrance approach described


here is based on the integration of a deodorized blend of Ascophyllum nodosum and Fucus serratus extracts into a fragrance-compatible formulation system comprising a perfume matrix and a dedicated solvent architecture. Deodorization of the algae blend is a prerequisite to minimize olfactory interference and preserve the intrinsic character of the fragrance. A central technical challenge lies in achieving


complete solubilization of the polar bioactive fractions within perfume concentrates. This is addressed through the combination of two solvent functionalities with complementary properties: one predominantly hydrophilic component, capable of interacting with polar algae-derived compounds, and one amphiphilic component, providing compatibility with the surrounding perfume matrix. The interplay between these two functionalities enables effective dispersion of the extract blend within the fragrance concentrate, yielding homogeneous and visually transparent systems without phase separation or turbidity. Stability is defined not only in terms of physical


appearance, but also with respect to preservation of colour, olfactory intensity, olfactory quality, and viscosity over time. Physical robustness is evaluated under accelerated ageing conditions and across a broad temperature range (5°C to 45°C) to ensure that the system remains stable and sensorially consistent, independently of the perfume type. From an industrial perspective, these criteria translate into actionable


performance benchmarks for formulation screening and quality control. Finally, the formulation is designed to


maintain measurable biological activity at use levels compatible with conventional fragrance incorporation in cosmetic products. This requirement is critical, as fragrance systems typically represent a limited fraction of the finished formulation. Under these conditions, the bioactive


fragrance system aims to deliver functional skin‑related effects while remaining physically and sensorially indistinguishable from a conventional fragrance concentrate, in finished products.


Materials and methods: assay principles for bioactivity The bioactive fragrance system was evaluated using in vitro assays designed to investigate mechanistic pathways relevant to skin well- ageing and tone uniformity. The selected assays target complementary biological functions commonly associated with cosmetic anti-ageing performance, including antioxidant capacity, regulation of melanogenesis, and inhibition of enzymes involved in extracellular matrix degradation. These in vitro methods are widely used in cosmetic research as part of a weight-of- evidence approach.1 Antioxidant activity was assessed using the ABTS radical cation decolorization assay,2,3


a


spectrophotometric method commonly employed to quantify radical-scavenging capacity. The reduction of the ABTSradical was monitored at


September 2026 PERSONAL CARE MAGAZINE


0.8


0.9


1


Inhibition (%)


Inhibition (%)


Inhibition (%)


Inhibition (%)


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92